100986-85-4 (左氧氟沙星,Levofloxacin)

左氧氟沙星;(-)9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶骈[1,2,3-DE]-[1,4]苯骈噁嗪-6-羧酸;可乐必妥;洛氟沙星;左旋葡聚糖;左旋氧氟沙星碱;左氟沙星·盐酸盐;1-(3-氨基-丙基)-氮杂环庚烷二盐酸盐;Levofloxacin 左氧氟沙星;乳酸左氧氟沙星;盐酸左氧氟沙星;氧氟沙星;氧氟沙星杂质;左旋氧氟沙星;左氧氟沙星 Levofloxacin Hydrochloride;左氧氟沙星 标准品;左氧氟沙星半水合物;利复星;左氟沙星;(S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧代-7H-吡啶[1,2,3-de]-1,4-苯并噁嗪-6-羧酸半水合物;(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶骈[1,2,3-DE]-[1,4]苯骈噁嗪-6-羧酸;洛夫沙星;左氧氟沙星碱;

ofloxacin;(s)-ofloxacin;7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylicacid,2,3-dihydro-9-fluoro-3-m;dr3355;hemihydrate,(s)-ethyl-10-(4-methyl-1-piperazinyl)-7-oxo;LEVOFLOXACIN HCL;LEVOFLOXACIN HEMIHYDRATE;(3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid monohydrochloride;Levofloxacin base;(-)-Ofloxacin;Levofloxacin;Levofloxacin Hydrochloride;NULL;Levofloxacin lactate;(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic ac;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6- carboxylic acid,9-fluoro-2,3-dihydro-3- methyl-10-(4-methyl-1-piperazinyl)-7-oxo-,(3S)-;Elequine;Iquix;Levaquin;Levaquin (TN);Levofloxacin [USAN:INN:JAN];Levofloxacine [INN-French];Levofloxacino [INN-Spanish];Ofloxacin S-(-)-form;(−)-Ofloxacin;LVFX;RWJ 25213;L-Ofloxacin;Ophthalmic;(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;Cravit;HR 355;Crarit;Tavanic;Quixin;Levofloxacine;Levofloxacino;Levofloxacinum;Oftaquix;Floxacin;(S)-(-)-Ofloxacin;Levofloxacinum [INN-Latin];Levofloxacin hydrate;Levofloxacin (Levaquin);LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTA;MLS001165709;HSDB 8028;UNII-6GNT3Y5LMF;GTPL10911;(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;EX-A1488;SPECTRUM1504260;Anhydrous Ofloxacin;NSC-758709;DTXSID60160533;s1940;Venaxan;Levofloxacin, analytical reference material;DR-3355;Levofloxacin (INN);RWJ-25213;KBio2_007335;Q-201295;Levofloxacin, >=98.0% (HPLC);HY-B0330;Z1590790198;Spectrum2_001676;CCRIS 4074;NSC758709;(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;Unibiotic;Levofloxacin, Antibiotic for Culture Media Use Only;Loxof;AS-31796;(S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid;Ofloxacin, (S)-Isomer;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-;MLS000759524;SR-05000001999-1;RIX4E89Y14;(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;KBioSS_002199;Aeroquin;()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;Dynaquin;NS00010154;KBioGR_001605;BDBM50366826;AB00171657-13;UNII-RIX4E89Y14;S-(-)-Ofloxacin;LEVOFLOXACIN (USP MONOGRAPH);CHEBI:63598;NCGC00178529-03;Ofloxcacin;Anhydrous, Levofloxacin;BRD-K09471561-001-18-2;NSC 758709;LEVOFLOXACIN (USP-RS);C07660;Spectrum_001719;DR-3355: L-isomer of ofloxacin;CCG-39093;AC-7593;LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER;Levofloxacin,(S);DB01137;Quinsair;DE-108;HMS1922J07;NC00094;AB00171657_15;AB00171657-12;AB00171657_14;J01MA12;OFLOXACIN S-(-)-FORM [MI];(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-;HR-355;MFCD00865049;LEVOFLOXACIN (MART.);Cravit IV;LEVOFLOXACIN [INN];NSC755604;HMS2093E18;(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;CPD000466387;Levofloxacin Anhydrous;L0193;(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;LFX;Spectrum5_001438;SMR000466387;HMS2090O10;LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER;RWJ 25213-097;NCGC00178529-02;fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid;(S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid;100986-85-4;NCGC00178529-06;MP-376;Pharmakon1600-01504260;KBio3_001909;Q424193;SCHEMBL15397;DTXCID2083024;Cravit (TN);HMS2232G06;(2S)-7-Fluoro-2-methyl-6-(4-methylpiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate;SPBio_001891;LEVOFLOXACIN [WHO-DD];Levofiexacin;S01AE05;SBI-0206768.P001;MMV687798;HMS2051G04;NSC-755604;NCGC00178529-01;Spectrum3_000995;Spectrum4_001123;DTXCID8021060;BRD-K09471561-001-06-7;SR-05000001999;MLS001423977;BSPBio_002689;KBio2_002199;(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;DTXSID0041060;AKOS015895104;MP 376;S-ofloxacin;(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid;LEVOFLOXACIN HEMIHYDRATE (EP MONOGRAPH);AKOS008901361;KBio2_004767;(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid;Ofloxacin s-(-)-form hemihydrate;D08120;

MFCD00865049

GSDSWSVVBLHKDQ-JTQLQIEISA-N

1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1

FC1C([H])=C2C(C(C(=O)O[H])=C([H])N3C2=C(C=1N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])[H])OC([H])([H])[C@]3([H])C([H])([H])[H])=O

4074

29349990

5385660

7327015